LEADER 01270nas  2200457-a 450 
001 9910137791803321
005 20230817213016.0
011   $a1557-7422
035   $a(DE-599)ZDB1498064-2
035   $a(OCoLC)41543640
035   $a(CKB)954925274479
035   $a(CONSER)---00256176-
035   $a(EXLCZ)99954925274479
100   $a19990615a19909999  s--         a
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHuman gene therapy
210   $aLarchmont, NY $cMary Ann Liebert, Inc
300   $aRefereed/Peer-reviewed
311   $aHuman gene therapy 1043-0342 (DLC)   91643656 (OCoLC)19283546 
531   $aHUM GENE THER
531   $aHUM GENE TH
531   $aHUM. GENE THER
606   $aGene therapy$vPeriodicals
606   $aGenetic Therapy
606   $aGene therapy$2fast$3(OCoLC)fst00939638
608   $aPeriodical
608   $aPeriodicals.$2fast
608   $aPeriodicals.$2lcgft
610   $aGenetics & Heredity
615  0$aGene therapy
615  2$aGenetic Therapy
615  7$aGene therapy.
676   $a616
906   $aJOURNAL
912   $a9910137791803321
996   $aHuman gene therapy$9796346
997   $aUNINA